Pembrolizumab is a humanized IgG4 monoclonal antibody that functions as a programmed death-1 (PD-1) inhibitor. It effectively blocks the interaction between PD-1 and its ligands, PD-L1 and PD-L2. This inhibition prevents the suppression of T-cell activity, typically mediated by PD-1 signaling in cells expressing these ligands, thereby enhancing the immune response against tumor cells. Pembrolizumab is utilized extensively in immunotherapy protocols for various cancers, leveraging its ability to modulate immune system responses.
Pembrolizumab is a humanized IgG4 monoclonal antibody that functions as a programmed death-1 (PD-1) inhibitor. It effectively blocks the interaction between PD-1 and its ligands, PD-L1 and PD-L2. This inhibition prevents the suppression of T-cell activity, typically mediated by PD-1 signaling in cells expressing these ligands, thereby enhancing the immune response against tumor cells. Pembrolizumab is utilized extensively in immunotherapy protocols for various cancers, leveraging its ability to modulate immune system responses.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
